JAKARTA, July 27 - PT Darya-Varia Laboratoria Tbk (“Darya-Varia”) has officially entered into a strategic partnership with PT Eisai Indonesia (“EISAI”) in the gastrointestinal therapy segment, as part of a shared commitment to expanding patient access to innovative, high-quality, and clinically proven healthcare solutions.

The partnership agreement was signed on July 16, 2025, in the presence of the management teams of Darya-Varia and EISAI. Today, the collaboration was formally announced at a ceremonial event held at Park Hyatt Jakarta, marking the readiness for commercial launch in the Indonesian market.

Under this agreement, Darya-Varia will serve as EISAI’s strategic marketing partner in Indonesia, leveraging its robust marketing capabilities and extensive reach across healthcare facilities nationwide. The collaboration is further supported by a trusted distribution partner to ensure optimal product availability and accessibility for patients.

This alliance marks a significant milestone for Darya-Varia in reinforcing its position as a preferred partner for multinational pharmaceutical companies in Indonesia. It is also aligned with the Company’s strategy to expand its therapeutic portfolio in line with evolving public health needs and to drive sustainable business growth.

“We are honored to bring EISAI’s leading gastrointestinal therapy to the Indonesian market. This innovative product is clinically proven and offers meaningful benefits to patients with digestive disorders,” said Dr. Ian Kloer, President Director of PT Darya-Varia Laboratoria Tbk. “This partnership reflects a strong strategic synergy—combining Darya-Varia’s deep local marketing expertise with EISAI’s strengths in clinical innovation—allowing us to deliver impactful healthcare solutions to more Indonesians.”

Dr. Iskandar Linardi, President Director of PT Eisai Indonesia, added, “As a company guided by innovation and the human health care (hhc) philosophy, we believe that industry collaboration is essential to improving access to meaningful therapies. Our partnership with Darya-Varia creates an opportunity to bring our treatments to a broader patient population in Indonesia. This synergy reflects our continued commitment to strengthening the national healthcare system.”

This collaboration marks the beginning of a new chapter between two companies that share a common vision—to enhance healthcare delivery in Indonesia by combining expertise, innovation, and a deep dedication to patient wellbeing.